Related Experiment Video
Updated: Sep 17, 2025

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
Published on: September 13, 2019
The PAX3-FOXO1 fusion gene reduces cell-ECM interactions and TGFβ signaling in rhabdomyosarcoma
Antonios Chronopoulos1, Ivan Chavez1, Chandra Kaladhar Vemula1
1Cancer and Blood Disease Institute, Children's Hospital Los Angeles , Los Angeles, CA, USA.
Abstract:
We identify downregulation of genes related to cell-ECM interactions and TGFβ signaling in FPRMS. We confirm that TGFβ signaling enhances cell-ECM interactions in FNRMS, utilizing confocal reflection microscopy to assess ECM remodeling, and a live-cell sensor to quantitatively assess TGFβ signaling. We also show that PAX3-FOXO1 increases NOS1 expression, stimulating nitric oxide synthesis, which inhibits TGFβ signaling and reduces cell-ECM interactions. We suggest that PAX3-FOXO1 reprograms ECM anchorage dependence by suppressing cell-ECM interactions. The fusion gene can determine sensitivity to growth inhibition via targeted disruption of cell-ECM interactions or TGFβ signaling. Reduced anchorage reliance by the gene may allow cells to survive in circulation and enhance FPRMS metastatic potential.
Insights
The PAX3-FOXO1 fusion gene in Ewing sarcoma downregulates cell-ECM interactions and TGFβ signaling, potentially driving metastasis by reducing anchorage dependence and enhancing cell survival.
Area of Science:
- Molecular Oncology
- Cell Biology
- Cancer Metastasis Research
Background:
- The PAX3-FOXO1 fusion gene is implicated in Ewing sarcoma (EWS).
- Cell-extracellular matrix (ECM) interactions and transforming growth factor beta (TGFβ) signaling are crucial in cancer progression.
Purpose of the Study:
- To investigate the role of PAX3-FOXO1 in regulating cell-ECM interactions and TGFβ signaling in Ewing sarcoma cells.
- To elucidate the mechanisms by which PAX3-FOXO1 influences EWS metastatic potential.
Main Methods:
- Gene expression analysis to identify downregulated pathways.
- Confocal reflection microscopy for ECM remodeling assessment.
- Live-cell biosensor to quantify TGFβ signaling activity.
- Nitric oxide synthase 1 (NOS1) expression and nitric oxide (NO) synthesis assays.
Main Results:
- Downregulation of cell-ECM interactions and TGFβ signaling genes was observed in PAX3-FOXO1-positive Ewing sarcoma (FPRMS).
- TGFβ signaling was confirmed to enhance cell-ECM interactions.
- PAX3-FOXO1 upregulates NOS1, increasing NO production, which inhibits TGFβ signaling and reduces cell-ECM interactions.
- PAX3-FOXO1 reprograms ECM anchorage dependence by suppressing cell-ECM interactions.
Conclusions:
- PAX3-FOXO1 alters cellular adhesion and signaling, potentially promoting EWS metastasis.
- Targeting cell-ECM interactions or TGFβ signaling may offer therapeutic strategies for EWS.
- Reduced anchorage dependence conferred by PAX3-FOXO1 may enhance tumor cell survival in circulation.
More Related Videos
09:58Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
Related Concept Videos
Abnormal Proliferation
TGF - β Signaling Pathway
Hedgehog Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
mTOR Signaling and Cancer Progression
The mTOR pathway or the...